PAR 0.00% 34.5¢ paradigm biopharmaceuticals limited..

TA view- all time high daily close, page-2

  1. 286 Posts.
    lightbulb Created with Sketch. 361
    Good question. Although it could be argued that the recent thrust has a lot to do with how undervalued PAR was post the successful trial.

    If there wasn't more potential news on the horizon then I'd definitely be looking for significant consolidation / correction to kick in. But it may take a bit of courage to walk away with as much potential news due in Q1/Q2 2019 such as....

    - Secondary end-point data (normally a bit ho hum - but in this case could provide strong evidence around the unique MOA of PPS given we will (hopefully) see the MRI results - a pure objective parameter that won't be subject to potential misinterpretation by the market)
    - MPS SAS - bearing in mind there could be a business built just around this indication
    - ex-NFL players - will raise news in the US - although I wonder how much interest there will be from American traders

    And there is a lot more to come too. The filing of the IND in Q3 CY2019 would be worthwhile waiting for alone.

    I'm pleased I didn't walk away mid-January - but am struggling to see why I'd walk away just yet - and particularly as there seems to best much potential upside around news

    Lots more to come

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
0.000(0.00%)
Mkt cap ! $120.9M
Open High Low Value Volume
35.5¢ 36.0¢ 34.5¢ $101.9K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 39147 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 21134 2
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
35.0¢
  Change
0.000 ( 1.92 %)
Open High Low Volume
35.0¢ 36.0¢ 34.5¢ 115057
Last updated 15.59pm 28/03/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.